S
SAB Biotherapeutics, Inc. (SABS)
NCM – Real vaqt narxi. Valyuta: USD
3.62
-0.10 (-2.69%)
Yopilishda: May 12, 2026, 4:00 PM EDT
3.60
-0.02 (-0.55%)
Bozor oldidan: May 13, 2026, 4:00 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
3.62
-0.10 (-2.69%)
Yopilishda: May 12, 2026, 4:00 PM EDT
3.60
-0.02 (-0.55%)
Bozor oldidan: May 13, 2026, 4:00 AM EDT
This stock has a consensus price target of $9.67 based on the ratings of 10 analysts. The high is $15.00 and the low is $6.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 6 | $ 9.67 | $ 15 |
| O’zgarish | 61.29% | 159.95% | 303.23% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-03-11 | 289.97% | Chardan Capital | $12 → $14 | Maintains | Buy |
| 2026-03-10 | 94.99% | HC Wainwright & Co. | $9 → $7 | Maintains | Buy |
| 2026-01-07 | 94.99% | UBS | $7 | Initiates Coverage On | Buy |
| 2025-12-19 | 317.83% | Guggenheim | $15 | Initiates Coverage On | Buy |
| 2025-12-18 | 234.26% | Chardan Capital | $12 → $12 | Maintains | Buy |